Bayer Stops Late-Stage Drug Trial
505877
Bayer HealthCare stopped a late-stage trial of Nexavar in patients with non-small cell lung cancer after a monitoring committee concluded the study would not improve overall survival.
256558
FRIDAY, Dec. 17 (HealthDayNews) -- The U.S. government announced Friday that it was halting the use of the painkiller Celebrex in a clinical trial on colorectal cancer patients after a study found an apparent increase in the risk of heart attack among those taking the drug.
90172
Merck Labs has pulled Vioxx, their arthritis drug, off the market after discovering during trials the possibility of a link to stroke or heart attack.
421903
In a surprising setback for the world's largest drugmaker, Pfizer Inc.  halted development on Saturday of its top experimental medicine, the cholesterol drug torcetrapib, due to safety concerns.
315903
A study testing whether naproxen would reduce the risk of Alzheimer's disease was halted after researchers noted an increase in heart attack and stroke among participants who were taking the pain reliever.
428235
Troubled hospital products maker Baxter  International Inc. on Thursday said it halted a late-stage  European trial of its experimental flu vaccine because of  higher-than-expected rates of fever.
738445
The Food and Drug Administration has given a Seattle company permission to resume its human tests of an experimental, gene-based arthritis treatment whose safety came into question this summer after a 36-year-old study participant died.
193595
A new study states that Bayer AG was too slow in withdrawing Baycol, a cholesterol-lowering medicine called a statin, from the market.
246773
A drug developed by Bayer AG and Onyx Pharmaceuticals shrank tumors in some liver cancer patients in a mid-stage trial and stabilized the disease, the companies said Wednesday.
203379
An international trial comparing blood-pressure lowering treatments has been stopped early due to the significantly better performance of one of the treatments in the trial.
398323
Still reeling from Merck&#39;s withdrawal of Vioxx from the market and Pfizer&#39;s decision to stop advertising Celebrex, people who suffer from arthritis pain now have one more worry: The US Food and Drug Administration announced Monday that it was halting a
43561
The editors of 11 top medical journals shook up the staid world of academic publishing this past week when they decided to stop printing results of drug trials that aren&#39;t registered in a central database.
37552
The drug giant Merck suspends trials on an HIV vaccine that was regarded as one of the most promising.
511798
A government-sponsored trial of Pfizer Inc.'s  blockbuster arthritis drug Celebrex was halted after patients taking the medicine had more than twice as many heart attacks as patients taking a placebo, the company said on Friday.
554464
BERLIN  - Drug maker Bayer AG said Monday it has reached settlements in  more than 2,800 cases related to the 2001 withdrawal of a cholesterol-lowering drug, paying nearly &#36;1.1 billion US in out-of-court deals.
127685
FRIDAY, Dec. 17 (HealthDayNews) -- The U.S. government announced Friday it has  halted the use of Celebrex in a cancer trial because of heart risks, and it is reviewing the safety of all its clinical trials using similar painkillers.
729710
Citing the &quot;interests of patient safety,&quot; US drug manufacturer Pfizer said it was stopping all clinical trials of the cholesterol-controlling drug Torcetrapib.